CapsoVision Reports Third Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: Nov 13, 2025
SARATOGA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results for its third quarter ended September 30, 2025.
Read more at globenewswire.com5.23
-0.1 (-1.88%)
Find more stocks in the Stock Screener
CV Latest News and Analysis
10 days ago - By: Chartmill
